Nipro chooses Virtumed

Following our 2020 introduction of the Nipro Guideplus guide catheter extension into South Africa we received an overwhelming thumbs up from the Cardiologists with regards to the products design and performance. The phenomenal reception to this equally phenomenal product triggered our discussions with Nipro in Japan to extend their range on offer in South Africa. These engagements were very positive and resulted in the launch of the Laxa range of specialized Angioplasty as well as the Goodman diagnostic catheters earlier in 2021 in South Africa. Now, it is with great pride that Virtumed can announce that as of 1 November 2021 we will solely distribute the interventional cardiology range going forward.


Leigh Childs, Manager Global Sales for Nipro says “I congratulate Simon and his team on a successful product launch of GuidePlus2. I look forward to working with the VirtuMed team in bringing more Nipro products to the market of South Africa”. Simon Swanich CEO, Virtumed adds “I have been delighted with how well the Nipro brand has been accepted onto the South African interventional cardiology market. Nipro has provided outstanding support in enabling the launch. Patients and Clinicians can be assured that their products are well supported with world class expertise, and can look forward to enhanced clinical outcomes in the near future”

Next Post